[Form 4] PRECIGEN, INC. Insider Trading Activity
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
PRECIGEN, INC. President and CEO Helen Sabzevari reported an exercise-and-sale transaction in company stock. On June 29, 2026, she exercised stock options to acquire 346,836 shares of common stock at $2.33 per share, then sold the same number of shares in open-market transactions at a weighted average price of $5.89 per share.
The sale was carried out under a pre-established Rule 10b5-1 trading plan and involved multiple trades between $5.75 and $6.04. After these transactions, she directly owns 3,768,872 shares of common stock and holds 500,164 stock options, so the sale represents a relatively small portion of her overall equity position.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 346,836 shares ($2,042,864)
Net Sell
3 txns
Insider
Sabzevari Helen
Role
President and CEO
Sold
346,836 shs ($2.04M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Option to Purchase Common Stock (Right to Buy) | 346,836 | $0.00 | -- |
| Exercise | Common Stock | 346,836 | $2.33 | $808K |
| Sale | Common Stock | 346,836 | $5.89 | $2.04M |
Holdings After Transaction:
Option to Purchase Common Stock (Right to Buy) — 500,164 shares (Direct, null);
Common Stock — 4,115,708 shares (Direct, null)
Footnotes (1)
- Represents shares sold pursuant to the terms of a 10b5-1 plan adopted by the reporting person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.75 to $6.04, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. The stock options are fully vested.